Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Asian Subjects with Human Immunodeficiency Virus 1 Infection: A Sub-Analysis of Phase 3 Clinical Trials

The efficacy and safety of a single tablet regimen (STR) of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) were analyzed in Phase 3 clinical trials in antiretroviral therapy (ART)-naïve and ART-experienced Asian subjects infected with human immunodeficiency virus (HI...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Jun Yong, Sungkanuparph, Somnuek, Anekthananon, Thanomsak, Sax, Paul, DeJesus, Edwin, Edelstein, Howard, Nelson, Mark, DeMorin, Jennifer, Liu, Hui C., Swamy, Raji, Bahn, Joonwoo, Hwang, SunJin, Yang, SangYoun, Ng, Christopher, Piontkowsky, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2016
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048004/
https://www.ncbi.nlm.nih.gov/pubmed/27704731
http://dx.doi.org/10.3947/ic.2016.48.3.219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048004/
https://www.ncbi.nlm.nih.gov/pubmed/27704731
http://dx.doi.org/10.3947/ic.2016.48.3.219

Ejemplares similares